Cabaletta Bio Inc [CABA] stock is trading at $2.49, up 7.33%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CABA shares have gain 2.05% over the last week, with a monthly amount glided 35.33%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Evercore ISI downgraded its rating to In-line on December 20, 2024, and dropped its price target to $6. On December 19, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $6 on the stock. UBS started tracking the stock assigning a Buy rating and suggested a price target of $10 on October 10, 2024. Jefferies initiated its recommendation with a Buy and recommended $36 as its price target on February 05, 2024. William Blair started tracking with a Outperform rating for this stock on November 29, 2023, and assigned it a price target of $38. In a note dated October 24, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $40 on this stock.
Cabaletta Bio Inc [CABA] stock has fluctuated between $0.99 and $5.46 over the past year. Currently, Wall Street analysts expect the stock to reach $16.33 within the next 12 months. Cabaletta Bio Inc [NASDAQ: CABA] shares were valued at $2.49 at the most recent close of the market. An investor can expect a potential return of 555.82% based on the average CABA price forecast.
Analyzing the CABA fundamentals
Gross Profit Margin for this corporation currently stands at -0.34% with Operating Profit Margin at -91.5%, Pretax Profit Margin comes in at -88.09%, and Net Profit Margin reading is -88.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.64, Equity is -0.92 and Total Capital is -0.82. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Cabaletta Bio Inc’s Current Ratio is 4.78. Also, the Quick Ratio is 4.78, while the Cash Ratio stands at 3.51.
